Bergmann NC, Davies MJ, Lingvay I, Knop FK (2023) Semaglutide for the treatment of overweight and obesity: a review
These early results provide a promising solution to a large segment of the US population struggling with the symptoms of diet-related disease
Our study now shows that if you are in a subgroup of long Covid patients who have autoantibodies circulating in your body, you may be a good candidate for these drugs." A commentary in Cell noted that the two studies provide compelling evidence that autoantibodies directly contribute to symptom generation in a subset of long Covid patients, while cautioning that neither provides definitive proof of a single central mechanism behind the condition
Gut 2023;72:1073-80.ArticlePubMedPMC 31
GLP-1 receptor agonists have been administered as subcutaneous injections
Senate Committee on Health, Education, Labor, and Pensions (HELP) hearing noted that Ozempic costs over 15 times more in the United States than in Germany), but still not necessarily affordable
